PVALB and schizophrenia: Indeed, a decrease in the expression of parvalbumin in patients with SZ in different brain regions including the hippocampus and prefrontal cortex has been a consistent finding in human post-mortem studies [56,73] and in animal models of schizophrenia [74–77].